We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+4.05%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$118M
AUM Growth
–
Cap. Flow
+$122M
Cap. Flow
% of AUM
103.01%
Top 10 Holdings %
Top 10 Hldgs %
7.37%
Holding
380
New
380
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booz Allen Hamilton
BAH
|
+$1M |
| 2 |
Verizon
VZ
|
+$937K |
| 3 |
MODV
ModivCare
MODV
|
+$925K |
| 4 |
EXL Service
EXLS
|
+$913K |
| 5 |
Iridium Communications
IRDM
|
+$894K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.09% |
| 2 | Industrials | 15.8% |
| 3 | Technology | 14.93% |
| 4 | Healthcare | 10.46% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
CVRx
CVRX
$126M
| $259K | 0.22% |
+20,480
| New | +$253K |
|
202
CryoPort
CYRX
$775M
| $259K | 0.22% |
+33,326
| New | +$248K |
|
203
Texas Roadhouse
TXRH
$12.7B
| $259K | 0.22% |
+1,436
| New | +$270K |
|
204
UDR
UDR
$12.9B
| $259K | 0.22% |
+5,962
| New | +$264K |
|
205
Griffon
GFF
$4.16B
| $259K | 0.22% |
+3,631
| New | +$263K |
|
206
Privia Health
PRVA
$3.21B
| $259K | 0.22% |
+13,231
| New | +$262K |
|
207
Alarm.com
ALRM
$2.56B
| $258K | 0.22% |
+4,242
| New | +$253K |
|
208
Norwegian Cruise Line
NCLH
$8.89B
| $258K | 0.22% |
+10,016
| New | +$253K |
|
209
Ingredion
INGR
$6.38B
| $257K | 0.22% |
+1,871
| New | +$263K |
|
210
Protolabs
PRLB
$1.86B
| $257K | 0.22% |
+6,582
| New | +$237K |
|
211
Gilat Satellite Networks
GILT
$810M
| $257K | 0.22% |
+41,772
| New | +$228K |
|
212
Kirby Corp
KEX
$7.95B
| $256K | 0.22% |
+2,423
| New | +$292K |
|
213
SolarEdge
SEDG
$2.59B
| $256K | 0.22% |
+18,826
| New | +$290K |
|
214
United Airlines
UAL
$38.4B
| $256K | 0.22% |
+2,633
| New | +$223K |
|
215
PRA Group
PRAA
$648M
| $255K | 0.22% |
+12,228
| New | +$261K |
|
216
Bunge Global
BG
$23.6B
| $255K | 0.22% |
+3,276
| New | +$288K |
|
217
Rambus
RMBS
$10.4B
| $253K | 0.21% |
+4,778
| New | +$244K |
|
218
Maximus
MMS
$3.14B
| $252K | 0.21% |
+3,378
| New | +$276K |
|
219
Ardmore Shipping
ASC
$678M
| $252K | 0.21% |
+20,707
| New | +$281K |
|
|
CLDT
220
Chatham Lodging
CLDT
$630M
| $251K | 0.21% |
+28,087
| New | +$249K |
|
221
Option Care Health
OPCH
$3.4B
| $251K | 0.21% |
+10,807
| New | +$273K |
|
222
Equity Lifestyle Properties
ELS
$12.8B
| $251K | 0.21% |
+3,763
| New | +$261K |
|
223
Applied Materials
AMAT
$426B
| $250K | 0.21% |
+1,536
| New | +$278K |
|
224
Kontoor Brands
KTB
$4.62B
| $249K | 0.21% |
+2,918
| New | +$250K |
|
225
Grindr
GRND
$2.64B
| $248K | 0.21% |
+13,903
| New | +$203K |
|
Similar funds
WA
BS
RG
MP
AIA
CCM
DFA
CCP
PharVision Advisers's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for PharVision Advisers, which disclosed 380 positions worth $118M. Its ten largest holdings account for 7.4% of the portfolio.
Its largest position is Booz Allen Hamilton: 6,467 shares worth $832K.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, followed by Industrials and Technology.
- PharVision Advisers's largest Q4 2024 buy was Booz Allen Hamilton: 6,467 shares worth $832K.
- PharVision Advisers's ten largest holdings make up 7.4% of its $118M portfolio in Q4 2024.
- PharVision Advisers disclosed 380 positions in Q4 2024, its first 13F filing on record.
Based on PharVision Advisers's 13F filing for Q4 2024, filed 18 Feb 2025.